CA2555862A1 - Analogues de polyamine qui activent le dephasage anti-enzyme - Google Patents

Analogues de polyamine qui activent le dephasage anti-enzyme Download PDF

Info

Publication number
CA2555862A1
CA2555862A1 CA002555862A CA2555862A CA2555862A1 CA 2555862 A1 CA2555862 A1 CA 2555862A1 CA 002555862 A CA002555862 A CA 002555862A CA 2555862 A CA2555862 A CA 2555862A CA 2555862 A1 CA2555862 A1 CA 2555862A1
Authority
CA
Canada
Prior art keywords
methyl
ethyl
hydrogen
aliphatic
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002555862A
Other languages
English (en)
Inventor
Mark R. Burns
Gerard F. Graminski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MediQuest Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2555862A1 publication Critical patent/CA2555862A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002555862A 2004-02-13 2004-03-29 Analogues de polyamine qui activent le dephasage anti-enzyme Abandoned CA2555862A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US04/04339 2004-02-13
PCT/US2004/009582 WO2005105729A1 (fr) 2004-02-13 2004-03-29 Analogues de polyamine qui activent le dephasage anti-enzyme

Publications (1)

Publication Number Publication Date
CA2555862A1 true CA2555862A1 (fr) 2005-11-10

Family

ID=34957315

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002555862A Abandoned CA2555862A1 (fr) 2004-02-13 2004-03-29 Analogues de polyamine qui activent le dephasage anti-enzyme

Country Status (4)

Country Link
EP (1) EP1730100A1 (fr)
AU (1) AU2004319105A1 (fr)
CA (1) CA2555862A1 (fr)
WO (1) WO2005105729A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
TWI389889B (zh) 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
US8017785B2 (en) 2006-05-09 2011-09-13 Astrazeneca Ab Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine
ES2298077B1 (es) * 2006-10-26 2009-08-07 Institut Quimic De Sarria Cets Nuevos sistemas polinitrogenados como agentes anti-vih.
US8258186B2 (en) 2009-07-16 2012-09-04 Pathologica, Llc Pharmaceutical for oral delivery comprising MGBG
US8703802B2 (en) 2010-05-20 2014-04-22 Targacept, Inc. Process for the preparation of aryl substituted olefinic amines
DK2943189T3 (da) 2013-01-08 2021-04-06 Pathologica Llc Mitoguazon til behandling af progressiv multipel sklerose
CA2913162C (fr) * 2013-05-22 2021-07-27 Curza Global, Llc Compositions et procedes comprenant une polyamine
US8853278B1 (en) 2013-05-22 2014-10-07 Curza Global, Llc Compositions comprising a biocidal polyamine
US9439433B2 (en) 2013-05-22 2016-09-13 Curza Global, Llc Compositions and methods comprising a biocidal polyamine
CN107406579B (zh) * 2015-03-31 2020-10-30 三菱瓦斯化学株式会社 环氧树脂固化剂、环氧树脂组合物、涂料、土木建筑用构件、固化物和复合材料、以及环氧树脂固化剂的制造方法
CA3058813A1 (fr) 2017-04-05 2018-10-11 University Of Utah Research Foundation Compositions et procedes comprenant une triaryl polyamine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE308515T1 (de) * 1999-02-05 2005-11-15 Oridigm Corp Antizymmodulatoren sowie deren verwendung
US7144920B2 (en) * 2002-09-23 2006-12-05 Mediquest Therapeutics, Inc. Polyamine analogs that activate antizyme frameshifting
US6914079B2 (en) * 2002-09-23 2005-07-05 Mediquest Therapeutics, Inc. Polyamine analogs that activate antizyme frameshifting

Also Published As

Publication number Publication date
AU2004319105A1 (en) 2005-11-10
WO2005105729A1 (fr) 2005-11-10
EP1730100A1 (fr) 2006-12-13

Similar Documents

Publication Publication Date Title
CA2555862A1 (fr) Analogues de polyamine qui activent le dephasage anti-enzyme
EP1379505B1 (fr) Inhibition de la kinase raf a l'aide d'urees de quinolyl, d'isoquinolyl ou de pyridyl
EP3700516B1 (fr) Inhibiteurs de l'induction de dux4 pour la régulation de la fonction musculaire
US6333337B1 (en) Potassium channel inhibitors
SG195568A1 (en) Nmda receptor antagonists for the treatment of neuropsychiatric disorders
WO2022067165A1 (fr) Agonistes sélectifs du récepteur 5-ht2a et procédés d'utilisation
UA61090C2 (uk) Фармацевтично прийнятна композиція та спосіб стимуляції росту невритів
US7144920B2 (en) Polyamine analogs that activate antizyme frameshifting
EP3774780B1 (fr) Composés et leur utilisation en tant qu'activateurs de pde4
KR20090116831A (ko) 카나비노이드의 새로운 용도
US6914079B2 (en) Polyamine analogs that activate antizyme frameshifting
JP6898310B2 (ja) ６員アザヘテロ環を含有するデルタ−オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法
EP4647430A1 (fr) Dérivé de tétrahydrothiophène et son utilisation en médecine
US12133839B2 (en) Cannabinoid derivatives and methods for their preparation
US9169247B2 (en) Tetrahydro-beta-carboline derivatives, synthesis and use thereof
EP1813636A1 (fr) Analogues de polyamine qui activent le déphasage anti-enzyme
HK1110613A (en) Polyamine analogs that activate antizyme frameshifting
JP6958860B2 (ja) ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途
AU718237B2 (en) Use of xanthine derivatives for the modulation of apoptosis
KR20230080977A (ko) 아니시아틴 에이를 유효성분으로 포함하는 미백용 조성물 및 상기 아니시아틴 에이 제조방법
JP2007537158A (ja) アンチザイムフレームシフトを活性化するポリアミン類似体
US10087148B2 (en) Quinazolines as biogenic amine transport modulators
US20050209264A1 (en) Tetrahydro-beta-carboline compounds and use thereof
CA1183437A (fr) 4-hydroxy-3-methoxy-n-[2-[2(1-methyl-2- piperidynyl)-ethyul] benzamide
EP1596856B1 (fr) Medicaments contenant des acides 2-arylaminoacetique substitues et/ou des acides 2-heteroarylaminoacetique substitues

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued